Patents-Review.com
🔗 Permalink
Assignee profile:

MDRNA, INC.

City:

Bothell, Washington

Country:

United States

Published Applications:

25

Last publication date:

2010-12-16

Patent Grants:

7

Last grant date:

2015-01-27

Top Inventors for applications by MDRNA, INC.

These are the the leading inventors for applications assigned to MDRNA, INC.:

Recent patent applications by MDRNA, INC.

MDRNA, INC. based in Bothell, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2010-12-16 ✅ Patent 8,940,857 granted on 2015-01-27
US20100316707A1
Human necessities

Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells

 #2 | 2010-12-09
US20100311655A1
Human necessities

INTRANASAL CARBETOCIN FORMULATIONS AND METHODS FOR THE TREATMENT OF AUTISM

 #3 | 2010-09-23
US20100240731A1
Human necessities

LIPOPEPTIDES FOR DELIVERY OF NUCLEIC ACIDS

 #4 | 2010-08-19
US20100210506A1
Human necessities

INTRANASAL ADMINISTRATION OF RAPID ACTING INSULIN

 #5 | 2010-07-22
US20100184688A1
Human necessities

COMPOSITIONS AND METHODS FOR ENHANCED MUCOSAL DELIVERY OF PARATHYROID HORMONE

 #6 | 2010-07-01
US20100166811A1
Human necessities

GRAS COMPOSITION FOR INTRANASAL DELIVERY OF PARATHYROID HORMONE

 #7 | 2010-06-10
US20100144843A1
Chemistry; metallurgy

RNAI THERAPEUTIC FOR RESPIRATORY VIRUS INFECTION

 #8 | 2010-06-03 ✅ Patent 7,772,189 granted on 2010-08-10
US20100137225A1
Chemistry; metallurgy

Phage displayed cell binding peptides

 #9 | 2010-05-06
US20100112687A1
Chemistry; metallurgy

NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB FAMILY GENE EXPRESSION AND USES THEREOF

 #10 | 2010-05-06
US20100112042A1
Human necessities

Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics

 #11 | 2010-04-29
US20100105134A1
Chemistry; metallurgy

NUCLEIC ACID COMPOUNDS FOR INHIBITING GENE EXPRESSION AND USES THEREOF

 #12 | 2010-03-04 ✅ Patent 8,314,227 granted on 2012-11-20
US20100056768A1
Chemistry; metallurgy

Hydroxymethyl substituted RNA oligonucleotides and RNA complexes

 #13 | 2010-03-04
US20100055784A1
Chemistry; metallurgy

NUCLEIC ACID COMPOUNDS FOR INHIBITING WNT GENE EXPRESSION AND USES THEREOF

 #14 | 2010-03-04
US20100055783A1
Chemistry; metallurgy

NUCLEIC ACID COMPOUNDS FOR INHIBITING RAS GENE EXPRESSION AND USES THEREOF

 #15 | 2010-03-04
US20100055782A1
Chemistry; metallurgy

NUCLEIC ACID COMPOUNDS FOR INHIBITING MYC GENE EXPRESSION AND USES THEREOF

 #16 | 2010-02-25
US20100047909A1
Chemistry; metallurgy

NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF

 #17 | 2010-02-18
US20100041140A1
Chemistry; metallurgy

NUCLEIC ACID COMPOUNDS FOR INHIBITING BCL2 GENE EXPRESSION AND USES THEREOF

 #18 | 2010-01-21
US20100015708A1
Chemistry; metallurgy

RIBONUCLEIC ACIDS WITH NON-STANDARD BASES AND USES THEREOF

 #19 | 2010-01-21
US20100015706A1
Chemistry; metallurgy

NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF

 #20 | 2009-02-12
US20090042823A1
Human necessities

USES OF BROAD SPECTRUM RNAI THERAPEUTICS AGAINST INFLUENZA

 #21 | 2009-02-12 ✅ Patent 8,299,236 granted on 2012-10-30
US20090042298A1
Chemistry; metallurgy

Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells

 #22 | 2009-01-15
US20090018097A1
Chemistry; metallurgy

MODIFICATION OF DOUBLE-STRANDED RIBONUCLEIC ACID MOLECULES

 #23 | 2007-11-01 ✅ Patent 7,696,343 granted on 2010-04-13
US20070253956A1
Human necessities

Method for opening tight junctions

 #24 | 2007-08-23 ✅ Patent 7,704,953 granted on 2010-04-27
US20070197444A1
Chemistry; metallurgy

Phage displayed cell binding peptides

 #25 | 2007-07-19 ✅ Patent 7,435,720 granted on 2008-10-14
US20070167364A1
Human necessities

Compositions and methods for enhanced mucosal delivery of parathyroid hormone
AssigneeID:

217780 ⎘